Ovarian Hypertension: Polycystic Ovary Syndrome

被引:51
作者
Bentley-Lewis, Rhonda [2 ,3 ]
Seely, Ellen [4 ]
Dunaif, Andrea [1 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[2] Massachusetts Gen Hosp, Diabet Res Ctr, Boston, MA 02114 USA
[3] Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA
[4] Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
Polycystic ovary syndrome; Hypertension; Hyperandrogenism; Insulin; Obesity; BODY-MASS INDEX; CARDIOVASCULAR RISK-FACTORS; IMPAIRED GLUCOSE-TOLERANCE; CORONARY-ARTERY-DISEASE; INTIMA-MEDIA THICKNESS; NORMAL-WEIGHT WOMEN; INSULIN-RESISTANCE; METABOLIC SYNDROME; BLOOD-PRESSURE; YOUNG-WOMEN;
D O I
10.1016/j.ecl.2011.01.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypertension is a significant contributor to the risk for cardiovascular disease. The increased prevalence of hypertension in women with polycystic ovary syndrome (PCOS) may contribute to the increased risk of cardiovascular disease in these women. Whether hypertension is associated with PCOS independent of obesity remains controversial. Nevertheless, detection and subsequent treatment of hypertension in this population should decrease the adverse sequelae from hypertensive cardiovascular disease. Treatment of risk factors inherent to PCOS, such as hyperandrogenism, insulin resistance, and obesity, may minimize the risk not only for the development of hypertension but also for incident cardiovascular disease independent of hypertension.
引用
收藏
页码:433 / +
页数:19
相关论文
共 119 条
[1]   Polycystic ovarian morphology with regular ovulatory cycles: Insights into the pathophysiology of polycystic ovarian syndrome [J].
Adams, JM ;
Taylor, AE ;
Crowley, WF ;
Hall, JE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (09) :4343-4350
[2]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[3]  
2-S
[4]  
[Anonymous], 2003, COCHRANE DB SYST REV
[5]   Treatment of polycystic ovary syndrome with spironolactone plus licorice [J].
Armanini, Decio ;
Castello, Roberto ;
Scaroni, Carla ;
Bonanni, Guglielmo ;
Faccini, Gianbattista ;
Pellati, Donatella ;
Bertoldo, Alessandro ;
Fiore, Cristina ;
Moghetti, Paolo .
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2007, 131 (01) :61-67
[6]   Glucose intolerance in obese adolescents with polycystic ovary syndrome:: Roles of insulin resistance and β-cell dysfunction and risk of cardiovascular disease [J].
Arslanian, SA ;
Lewy, VD ;
Danadian, K .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (01) :66-71
[7]   A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain [J].
Asunción, M ;
Calvo, RM ;
San Millán, JL ;
Sancho, J ;
Avila, S ;
Escobar-Morreale, HF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (07) :2434-2438
[8]   Androgen excess in women: Experience with over 1000 consecutive patients [J].
Azziz, R ;
Sanchez, LA ;
Knochenhauer, ES ;
Moran, C ;
Lazenby, J ;
Stephens, KC ;
Taylor, K ;
Boots, LR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (02) :453-462
[9]   The prevalence and features of the polycystic ovary syndrome in an unselected population [J].
Azziz, R ;
Woods, KS ;
Reyna, R ;
Key, TJ ;
Knochenhauer, ES ;
Yildiz, BO .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) :2745-2749
[10]   Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An Androgen Excess Society guideline [J].
Azziz, Ricardo ;
Carmina, Enrico ;
Dewailly, Didier ;
Diamanti-Kandarakis, Evanthia ;
Escobar-Morreale, Hector F. ;
Futterweit, Walter ;
Janssen, Onno E. ;
Legro, Richard S. ;
Norman, Robert J. ;
Taylor, Ann E. ;
Witchel, Selma F. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (11) :4237-4245